FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Shoolin Pharma Chem Tadalafil Recall

TADALAFIL USP, 0

Shoolin Pharma Chem LLP

Risk level
Class II
Reported by FDA
Aug 19, 2026
Recall ID
D-0760-2026
Check your lot numberHow we source this data

Summary

Shoolin Pharma Chem recalled Tadalafil starting Aug 3, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0760-2026 on Aug 19, 2026. Reason: CGMP Deviations:Noted during FDA inspection. Status: Ongoing.

Why it was recalled

CGMP Deviations:Noted during FDA inspection

Product description

TADALAFIL USP, 0.100 KG, 0.1KG(100gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO 1715996-29-5), NDC 85702-002-02.

Lot numbers, UPCs & expiration codes

Lot: TLF2506001, Date of Expiry: May 31, 2028.

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0760-2026
Classification
Class II
Status
Ongoing
Recall initiated
Aug 3, 2026
FDA report date
Aug 19, 2026
Quantity
1KG - 100-0.1KG(100gm) bags
Recall type
Voluntary: Firm initiated
Recalling firm
Shoolin Pharma Chem LLP

Original FDA data

Every field from FDA enforcement report D-0760-2026, exactly as published.

Show all FDA fields
City
Kadi
Status
Ongoing
Country
India
Event ID
99547
Address
408 B/H Ratnamani Tubes
Address (line 2)
Block/Survey No; Nr Maruti Inox
Code information
Lot: TLF2506001, Date of Expiry: May 31, 2028.
Report date
Aug 19, 2026
Product type
Drugs
Recall number
D-0760-2026
Classification
Class II
Recalling firm
Shoolin Pharma Chem LLP
Product quantity
1KG - 100-0.1KG(100gm) bags
Reason for recall
CGMP Deviations:Noted during FDA inspection
Voluntary / mandated
Voluntary: Firm initiated
Product description
TADALAFIL USP, 0.100 KG, 0.1KG(100gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO 1715996-29-5), NDC 85702-002-02.
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Aug 3, 2026
Center classification date
Aug 13, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0760-2026, published Aug 19, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls